Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

SecurityKRYS / Krystal Biotech, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership1,138 shares
Latest Disclosed Value $ 293,968
Squarepoint Ops LLC ownership in KRYS / Krystal Biotech, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 1,138 shares of Krystal Biotech, Inc. (US:KRYS) valued at $293,968 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on August 27, 2025 disclosing 0 shares of Krystal Biotech, Inc.. The current value of the position is $343,471 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (KRYS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KRYS / Krystal Biotech, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 1,138 1,138 294 0.0003
2025-08-27 2025-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 0 -81,999 -100.00 0 -100.00
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 0 -81,999 0
2025-08-27 2025-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 81,999 72,440 757.82 14,784 887.58 0.0179
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 81,999 72,440 14,784 0.0179
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 9,559 -6,147 -39.14 1,498 -47.62 0.0015
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 15,706 13,298 552.24 2,859 546.61 0.0045
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 2,408 2,408 442 0.0007
2024-05-15 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 0 -3,709 -100.00 0 -100.00
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 3,709 3,709 460 0.0009
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 0 -8,320 -100.00 0 -100.00
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 8,320 8,320 580 0.0029
2022-05-16 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 0 -21,794 -100.00 0 -100.00
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 21,794 8,909 69.14 1,524 126.45 0.0040
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 12,885 8,384 186.27 673 119.93 0.0019
2021-08-16 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 4,501 4,501 306 0.0012
2020-11-16 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 0 -5,758 -100.00 0 -100.00
2020-08-14 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 5,758 5,758 238 0.0039
2020-05-15 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 0 -11,762 -100.00 0 -100.00
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 11,762 -20,147 -63.14 651 -41.25 0.0039
2019-11-14 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 31,909 -7,519 -19.07 1,108 -30.23 0.0099
2019-08-14 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 39,428 32,777 492.81 1,588 625.11 0.0155
2019-05-15 2019-03-31 13F KRYSTAL BIOTECH COM 501147102 6,651 6,651 -83.13 219 -86.21 0.0023
2018-05-15 2018-03-31 13F KRYSTAL BIOTECH COM 501147102 0 -10,800 -100.00 0 -100.00
2018-02-14 2017-12-31 13F KRYSTAL BIOTECH COM 501147102 10,800 10,800 114 0.0020
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM Call 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM Call 1,500 370 n/a n/a n/a
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM Call 2,600 473 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM Put 4,800 874 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.